Lexicon Stock Buy Hold or Sell Recommendation

LXRX
 Stock
  

USD 2.13  0.09  4.05%   

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Lexicon Pharmaceutcl is 'Cautious Hold'. Macroaxis provides Lexicon Pharmaceutcl buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding LXRX positions. The advice algorithm takes into account all of Lexicon Pharmaceutcl's available fundamental, technical, and predictive indicators you will find on this site.
  
The advice is provided from Lexicon Pharmaceutcl's buy-and-hold perspective. Additionally, see Lexicon Pharmaceutcl Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Lexicon and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Lexicon Pharmaceutcl.

Execute Lexicon Pharmaceutcl Buy or Sell Advice

The Lexicon recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Lexicon Pharmaceutcl. Macroaxis does not own or have any residual interests in Lexicon Pharmaceutcl or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Lexicon Pharmaceutcl's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Lexicon PharmaceutclBuy Lexicon Pharmaceutcl
Cautious Hold

Volatility

Details

Hype Condition

Details

Current Valuation

Details

Odds of Distress

Details

Economic Sensitivity

Details

Analyst Consensus

Details

Financial Strenth (F Score)

Details

Financial Leverage

Inapplicable
Details

Reporting Quality (M-Score)

Details
For the selected time horizon Lexicon Pharmaceutcl has a Mean Deviation of 3.04, Standard Deviation of 3.94 and Variance of 15.52
We provide investment recommendation to complement the last-minute expert consensus on Lexicon Pharmaceutcl. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the entity's potential to grow using all technical and fundamental data available at the time. To make sure Lexicon Pharmaceutcl is not overpriced, please verify all Lexicon Pharmaceutcl fundamentals, including its cash and equivalents, cash flow from operations, market capitalization, as well as the relationship between the debt to equity and price to earnings to growth . Please also check out Lexicon Pharmaceutcl price to book to check your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Lexicon Pharmaceutcl Trading Alerts and Improvement Suggestions

Lexicon Pharmaceutcl generated a negative expected return over the last 90 days
Lexicon Pharmaceutcl has high historical volatility and very poor performance
The company reported the previous year's revenue of 125 K. Net Loss for the year was (97.06 M) with loss before overhead, payroll, taxes, and interest of (54.75 M).
Lexicon Pharmaceutcl currently holds about 136.2 M in cash with (90.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.72.
Over 82.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: The Global Clinical Diagnostics Market is expected to Surge at a CAGR of 7.02 percent During the Forecast Period DelveInsight - Yahoo Finance

Lexicon Pharmaceutcl current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Lexicon analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Lexicon analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price13.00
Target Median Price13.00
Target High Price16.00
Recommendation Mean2.00
Number Of Analyst Opinions2
Target Low Price10.00
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Lexicon Pharmaceutcl Returns Distribution Density

The distribution of Lexicon Pharmaceutcl's historical returns is an attempt to chart the uncertainty of Lexicon Pharmaceutcl's future price movements. The chart of the probability distribution of Lexicon Pharmaceutcl stock daily returns describes the distribution of returns around its average expected value. We use Lexicon Pharmaceutcl price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Lexicon Pharmaceutcl returns is essential to provide solid investment advice for Lexicon Pharmaceutcl.
Mean Return-0.46Value At Risk-6.11
Potential Upside5.80Standard Deviation3.94
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Lexicon Pharmaceutcl historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Lexicon Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Lexicon Pharmaceutcl is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Lexicon Pharmaceutcl backward and forwards among themselves. Lexicon Pharmaceutcl's institutional investor refers to the entity that pools money to purchase Lexicon Pharmaceutcl's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Zurcher Kantonalbank Zurich CantonalbankCommon Shares12.7 K24 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares12.7 K27 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares12.7 K50 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares4.2 KK
Zurcher Kantonalbank Zurich CantonalbankCommon Shares4.2 K17 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares4.2 K13 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares4.2 K26 K
Note, although Lexicon Pharmaceutcl's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Lexicon Pharmaceutcl Cash Flow Accounts

201720182019202020212022 (projected)
Capital Expenditure(228 K)(95 K)(70 K)10.93 M(1.22 M)(1.25 M)
Depreciation Amortization and Accretion3.4 M3.68 M3.65 M2.93 M292 K299.68 K
Net Cash Flow or Change in Cash and Cash Equivalents15.06 M18.73 M(44.27 M)90.15 M(62.2 M)(63.83 M)
Issuance Purchase of Equity Shares6.31 M(240 K)(941 K)68.94 M34.41 M37.68 M
Issuance Repayment of Debt Securities143.62 M(2 M)(1.28 M)(216.58 M)(11.7 M)(12.01 M)
Net Cash Flow from Financing149.93 M(2.24 M)(2.23 M)(147.64 M)22.71 M23.31 M
Net Cash Flow from Investing50.52 M169.58 M(155.85 M)380.76 M2.11 M2.17 M
Net Cash Flow Investment Acquisitions and Disposals50.75 M169.67 M(155.78 M)209.44 M3.33 M3.42 M
Net Cash Flow from Operations(185.39 M)(148.61 M)113.81 M(142.97 M)(87.02 M)(93.89 M)
Share Based Compensation9.47 M11.7 M14.22 M13.27 M10.58 M10.84 M

Lexicon Pharmaceutcl Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Lexicon Pharmaceutcl or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Lexicon Pharmaceutcl's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Lexicon stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
-0.58
β
Beta against DOW1.68
σ
Overall volatility
3.94
Ir
Information ratio -0.14

Lexicon Pharmaceutcl Volatility Alert

Lexicon Pharmaceutcl exhibits very low volatility with skewness of 0.87 and kurtosis of 1.78. However, we advise investors to further study Lexicon Pharmaceutcl technical indicators to ensure that all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Lexicon Pharmaceutcl's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Lexicon Pharmaceutcl's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Lexicon Pharmaceutcl Fundamentals Vs Peers

Comparing Lexicon Pharmaceutcl's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Lexicon Pharmaceutcl's direct or indirect competition across all of the common fundamentals between Lexicon Pharmaceutcl and the related equities. This way, we can detect undervalued stocks with similar characteristics as Lexicon Pharmaceutcl or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Lexicon Pharmaceutcl's fundamental indicators could also be used in its relative valuation, which is a method of valuing Lexicon Pharmaceutcl by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Lexicon Pharmaceutcl to competition
FundamentalsLexicon PharmaceutclPeer Average
Return On Equity(69.18) %(0.31) %
Return On Asset(32.90) %(0.14) %
Current Valuation313.4 M16.62 B
Shares Outstanding188.73 M571.82 M
Shares Owned by Insiders1.00 %10.09 %
Shares Owned by Institutions82.27 %39.21 %
Number of Shares Shorted4.26 M4.71 M
Price to Earning21.02 X28.72 X
Price to Book2.87 X9.51 X
Revenue125 K9.43 B
Gross Profit(54.75 M)27.38 B
EBITDA(95.38 M)3.9 B
Net Income(97.06 M)570.98 M
Cash and Equivalents136.2 M2.7 B
Cash per Share0.72 X5.01 X
Total Debt30.63 M5.32 B
Debt to Equity0.21 %48.70 %
Current Ratio7.54 X2.16 X
Book Value Per Share0.76 X1.93 K
Cash Flow from Operations(90.11 M)971.22 M
Short Ratio8.40 X4.00 X
Earnings Per Share(0.61) X3.12 X
Price to Earnings To Growth(0.07) X4.89 X
Number of Employees8718.84 K
Beta1.36-0.15
Market Capitalization413.31 M19.03 B
Total Asset284.2 M29.47 B
Retained Earnings(1.45 B)9.33 B
Working Capital139.74 M1.48 B
Current Asset171.5 M9.34 B
Current Liabilities31.77 M7.9 B
Z Score0.88.72
   Lexicon Pharmaceutcl exotic insider transaction detected [view details]

About Lexicon Pharmaceutcl Buy or Sell Advice

When is the right time to buy or sell Lexicon Pharmaceutcl? Buying financial instruments such as Lexicon Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2019 2021 2022 (projected)
Receivables56.53 M14 K14.37 K
Inventories4.24 M3.82 M3.54 M

Use Investing Ideas to Build Portfolios

In addition to having Lexicon Pharmaceutcl in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Top Cryptocurrency Thematic Idea Now

Top Cryptocurrency
Top Cryptocurrency Theme
Dynamically computed list of top cryptocurrencies sorted bymarket capitalization. The Top Cryptocurrency theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Top Cryptocurrency Theme or any other thematic opportunities.
View All  Next Launch
Additionally, see Lexicon Pharmaceutcl Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for analysis

When running Lexicon Pharmaceutcl price analysis, check to measure Lexicon Pharmaceutcl's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexicon Pharmaceutcl is operating at the current time. Most of Lexicon Pharmaceutcl's value examination focuses on studying past and present price action to predict the probability of Lexicon Pharmaceutcl's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Lexicon Pharmaceutcl's price. Additionally, you may evaluate how the addition of Lexicon Pharmaceutcl to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Is Lexicon Pharmaceutcl's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lexicon Pharmaceutcl. If investors know Lexicon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lexicon Pharmaceutcl listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
(0.63) 
Market Capitalization
402 M
Quarterly Revenue Growth YOY
0.7
Return On Assets
(0.33) 
Return On Equity
(0.69) 
The market value of Lexicon Pharmaceutcl is measured differently than its book value, which is the value of Lexicon that is recorded on the company's balance sheet. Investors also form their own opinion of Lexicon Pharmaceutcl's value that differs from its market value or its book value, called intrinsic value, which is Lexicon Pharmaceutcl's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lexicon Pharmaceutcl's market value can be influenced by many factors that don't directly affect Lexicon Pharmaceutcl's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lexicon Pharmaceutcl's value and its price as these two are different measures arrived at by different means. Investors typically determine Lexicon Pharmaceutcl value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lexicon Pharmaceutcl's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.